Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study
Lin Fu, Jun Fei, Xu Shen, Hui-Xian Xiang, Ying Xiang, Biao Hu, Meng‐Die Li, Fangfang Liu, Ying Li, Xiuyong Li, Hui Zhao, De‐Xiang Xu
Abstract
Background and Aims: Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease caused by severe acute respiratory syndrome coronavirus-2 (commonly known as SARS-CoV-2) with multiple organ injuries. The aim of this study was to analyze COVID-19-associated liver dysfunction (LD), its association with the risk of death and prognosis after discharge.
Topics & Concepts
MedicineHypoproteinemiaInternal medicineCase fatality rateLiver diseaseProspective cohort studyCholestasisRelative riskGastroenterologyEpidemiologyConfidence intervalCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLiver Disease Diagnosis and Treatment